核素显像在肾脏疾病评价中的临床应用

兰晓莉; 李春艳

doi:10.13201/j.issn.1001-1420.2015.10.001

核素显像在肾脏疾病评价中的临床应用

兰晓莉^,,
李春艳

- 华中科技大学同济医学院附属协和医院核医学科(武汉, 430022)

详细信息

通讯作者: 兰晓莉,E-mail:hzslxl@163.com

中图分类号: R445.5

收稿日期: 2015-09-07

Clinical application of nuclide imaging in renal diseases

LAN Xiaoli^,,
LI Chunyan

- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

More Information

Corresponding author: LAN Xiaoli, E-mail: hzslxl@163.com

Received Date: 07 September 2015

摘要

摘要: 核素肾脏显像在肾脏疾病中具有重要的临床价值。肾动态显像结合利尿试验有助于鉴别尿路梗阻的性质,制定急性肾绞痛患者的治疗决策。在肾移植术前供体筛查、术后并发症监测和移植肾功能监测都有重要价值。血管紧张素受体抑制剂介入试验有利于诊断肾血管性高血压,并预测术后的转归。分肾功能测量为多种疾病尤其是慢性肾脏疾病患者提供了不可替代的信息。
- 核素显像 /
- 分肾功能 /
- 肾移植 /
- 尿路梗阻 /
- 肾血管性高血压
Abstract: Renal scintigraphy is mainly applied for quantitative evaluation of renal function. Diuretic renography aids to differentiate between urinary obstruction and unobstructed dilation, which makes critical decisions in acute renal colic settings. It could also be utilized to screen for living kidney donors, detect post-transplant complications and monitor graft function. Angiotensin-converting enzyme inhibitor renography takes a part in detection of renovascular hypertension and outcome prediction after surgical intervention. Split renal function measurement provides indispensable information especially for chronic kidney disease.
- renal scintigraphy /
- split kidney function /
- renal transplantation /
- urinary obstruction /
- renovascular hypertension

HTML全文

参考文献(22)

[1]	Sfakianakis G N, Cohen D J, Braunstein R H,et al.MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith[J]. J Nucl Med,2000,41(11):1813-1822.
[2]	Taylor A T.Radionuclides in nephrourology, Part 2:pitfalls and diagnostic applications[J]. J Nucl Med, 2014,55(5):786-798.
[3]	Vlajković M, Ilić S, Rajić M, et al. Diuresis renal scintigraphy "F-0" in diagnosing of upper urinary tract obstruction in children:the clinical significance[J]. Nucl Med Rev Cent East Eur, 2005, 8(1):21-27.
[4]	Vittori M, D'Addessi A, Pinto F, et al. (99m)Tc-MAG3 diuretic renography in assessment of obstructive uropathy. The new test F+10SP:a step ahead in the differential diagnosis[J]. Urologia, 2011, 78(3):221-226.
[5]	Shokeir A A,Gad H M,el-Diasty T.Role of radioisotope renal scans in the choice of nephrectomy side in live kidney donors[J].J Urol,2003,170(2 Pt 1):373-376.
[6]	Diez A, Powelson J, Sundaram C P,et al.Correlation between CT-based measured renal volumes and nuclear-renography-based split renal function in living kidney donors. Clinical diagnostic utility and practice patterns[J]. Clin Transplant, 2014, 28(6):675-682.
[7]	Huh K H, Yun M, Kim T S, et al. Measurement of donor kidney functional renal volume and glomerular filtration rate to predict allograft function during the post-transplantation period[J]. Nephron Clin Pract, 2009, 113(4):c262-269.
[8]	Weinberger S, Baeder M, Scheurig-Muenkler C, et al. Optimizing scintigraphic evaluation of split renal function in living kidney donors using the geometric mean method:a preliminary retrospective study[J]. J Nephrol, 2015.
[9]	Yazici B, Yazici A, Oral A, et al. Comparison of renal transplant scintigraphy with renal resistance index for prediction of early graft dysfunction and evaluation of acute tubular necrosis and acute rejection[J]. Clin Nucl Med, 2013, 38(12):931-935.
[10]	Yazici B, Oral A, Gokalp C, et al.Evaluation of Renal Transplant Scintigraphy and Resistance Index Performed Within 2 Days After Transplantation in Predicting Long-Term Graft Function[J]. Clin Nucl Med, 2015, 40(7):548-552.
[11]	Gupta S K, Lewis G, Rogers K, et al.Quantitative Tc-99m DTPA renal transplant scintigraphy predicts graft survival in the very early postoperative period[J]. Nucl Med Commun, 2012, 33(12):1292-1299.
[12]	Guignard R, Mourad G, Mariano-Goulart D. Utility of postsurgical renal scintigraphy to predict one-year outcome of renal transplants in patients with delayed graft function[J]. Nucl Med Commun, 2011, 32(4):314-319.
[13]	Kwon T, Jeong I G, Yoo S, et al. Role of MRI in indeterminate renal mass:diagnostic accuracy and impact on clinical decision making[J]. Int Urol Nephrol, 2015, 47(4):585-593.
[14]	Nicolau C, Buñesch L, Paño B, et al.Prospective evaluation of CT indeterminate renal masses using US and contrast-enhanced ultrasound[J]. Abdom Imaging, 2015, 40(3):542-551.
[15]	Grüning T, Drake B E, Freeman S J. Single-photon emission CT using (99m)Tc-dimercaptosuccinic acid (DMSA) for characterization of suspected renal masses[J]. Br J Radiol, 2014, 87(1039):20130547.
[16]	Wang H Y, Ding H J, Chen J H, et al. Meta-analysis of the diagnostic performance of[18F] FDG-PET and PET/CT in renal cell carcinoma[J]. Cancer Imaging, 2012, 12:464-474.
[17]	兰晓莉. ¹⁸F-FDG PET/CT显像在泌尿系统肿瘤中的临床应用[J]. 临床泌尿外科杂志, 2014, 29(10):851-854.
[18]	Prigent A. Monitoring renal function and limitations of renal function tests[J]. Semin Nucl Med, 2008, 38(1):32-46.
[19]	Macunluoğlu B, G kçe I, Atakan A, et al. A comparison of different methods for the determination of glomerular filtration rate in elderly patients with chronic renal failure[J]. Int Urol Nephrol, 2011, 43(1):257-263.
[20]	Cheng M H, Zeng F W, Xie L J, et al. A new quantitative method for estimating glomerular filtration rate and its clinical value[J]. Clin Physiol Funct Imaging, 2014.
[21]	Taylor A T Jr, Fletcher J W, Nally J V Jr, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine[J]. J Nucl Med, 1998, 39(7):1297-1302.
[22]	Taylor A. Functional testing:ACEI renography[J]. Semin Nephrol, 2000,20(5):437-444.